Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,293,000
-$1,904,000 QoQ
Shares Held
350,000
0.0% QoQ
Ownership
0.716%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TANG CAPITAL MANAGEMENT LLC holds $1,792,526,680 across 34 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUPH |
Aurinia Pharmaceuticals Inc.
|
13,044,106 | $221,358,478 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
1,892,200 | $167,989,516 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,236,027 | $144,701,680 | |
| 4 | CELC |
Celcuity Inc.
|
1,314,594 | $137,532,824 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
1,500,000 | $130,425,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,500,000 | $122,355,000 | |
| 7 | LKFT |
Lakefront Biotherapeutics NV
|
3,785,991 | $113,504,010 | |
| 8 | CAPR |
Capricor Therapeutics, Inc.
|
4,099,900 | $98,725,592 |
All Filings in URGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,293,000 | 350,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $8,197,000 | 350,000 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $19,950,000 | 1,000,000 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $13,700,000 | 1,000,000 | Shares | Other | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||